Form D · Other Health Care
SIMBIONIX USA CORP
Cleveland, OH · CIK 0001446281
Offering snapshot reported Nov 12, 2008 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2008 | Initial | $7,000,000 | No comparison | Not reported | SEC filing |
| Sep 23, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-122918
Source: Form D, filed Nov 12, 2008. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Avshalom Horan | Director |
| Robert J. Massie | Director |
| James M. Petras | Director |
| Murray Wilson | Director |
| Gary Zamler | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11000 Cedar Avenue Suite 210
Cleveland, OH, 44106
Cleveland, OH, 44106